Serotonin transporter gene promoter polymorphism is associated with body mass index and obesity in non-elderly stroke patients

Journal of Endocrinological Investigation

Volumn 32, Issue 2, 2009, Pages 119-122

  Lan, M Y ^a   Chang, Y Y ^a   Chen, W H ^a   Kao, Y F ^a   Lin, H S ^a   Liu, J S ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Body mass index; Obesity; Polymorphism; Serotonin transporter; Stroke

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; ELDERLY CARE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBESITY; PROMOTER REGION; STROKE;

EID: 67649344676     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345699     Document Type: Article

References (24)

1. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med 2002, 162: 1867-72.
2. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002, 162: 2557-62.
3. Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke 2004, 35: 831-6.
4. Dagenais GR, Yi 0, Mann JF, Bosch J, Pough J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005, 149: 54-60.
5. Oki I, Nakamura Y, Okamura T, et al; Nippon Data8O Research Group. Body mass index and risk of stroke mortality among a random sample of Japanese adults: 19-year follow-up of NIPPON DATA8O. Cerebrovasc Dis 2006, 22: 409-15.
6. Razinia T, Saver JL, Liebeskind DS, All LK, Buck B, Ovbiagele B. Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol 2007, 64: 388-91.
7. Muldoon ME, Mackey RH, Williams V. Korytkowski MT, Flory JD, Manuck SB. Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity. J Clin Endocrinol Metab 2004, 89: 266-71.
8. Rossi-Fanelli F, Laviano A. Role of brain tryptophan and serotonin in secondary anorexia. Adv Exp Med Biol 2003, 527: 225-32.
9. Blundell JE. Serotonin manipulations and the structure of feeding behaviour. Appetite 1986, 7 (Suppl): 39-56.
10. Wurtman JJ, Wurtman RJ. D-fenfluramine selectively decreases carbohydrate but not protein intake in obese subjects. Int J Obes 1984, 8 (Suppl 1): 79-84.
11. Bross R, Hoffer U. Fluoxetine increases resting energy expenditure and basal body temperature in humans. Am J Clin Nutr 1995, 61: 1020-5.
12. Fernstrom MH. Depression, antidepressants, and body weight change. Ann N YAcad Sci 1989, 575: 31-9.
13. Owens MJ, Nemeroff CS. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994, 40: 288-95.
14. Ramamoorthy 5, Bauman AL, Moore KR, et al. Antidepressant and cocaine sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proc NatI Acad Sci USA 1993, 90: 2542-6.
15. Leach KP, Bengel D, Hells A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274: 1527-31.
16. Sookoian 5, Gemn,a C, Garcia SI, et al. Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) 2007, 15: 27 1-6.
17. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Geneva, Switzerland: World Health Organization, 2000.
18. Heinz A, Jones DW, Mazzanti C, et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. BioI Psychiatry 2000, 47: 643-9.
19. Collin M, Hàkansson-Ovesjö ML, Misane I, Ögren SO, Meister B. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese Ieptin-deficient ob/ob mouse. Mol Brain Res 2000, 81: 51-61.
20. Kuikka JT, Tammela L, Karhunen L, et al. Reduced serotonin transporter binding in binge eating women. Psychopharmacology 2001, 155: 310-4.
21. Corbalán MS, Marti A, Forga L, MartInez-Gonzalez MA, Martinez JA. The risk of obesity and the Trp64Arg polymorphism of the β3-adrenergic receptor: Effect modification by age. Ann Nutr Metab 2002, 46: 152-8.
22. Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med 2005, 35: 101-11.
23. Joyce PR, Mulder RT, Luty SE, et al. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharrnacol 2003, 6: 339-46.
24. Bodurtha JN, Mosteller M, Hewitt JK, et al. Genetic analysis of an thropometric measures in 11-year-old twins: the Medical College of Virginia Twin Study. Pediatr Res 1990, 28: 1-4.